MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
CorVita Science Foundation · NCT06455488
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 130
- US sites recruiting
- 1
- Study start
- July 20, 2020
- Record last updated
- June 12, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
Being studied: Ventricular Tachycardia Ablation; ICD Implant; Antiarrhythmic drug; EKG; Cardioversion; Echocardiogram
Conditions: Ventricular Tachycardia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Must be at least 18 years old
- Must not be
Exclusion Criteria
-
Recruiting US locations
Corvita Science Foundation
Chicago, IL 60643
Site contact: Martin C Burke, DO · 773-520-8322 · mburke@corvitahealth.org
Study contacts (from the official record)
- Martin C Burke, DO · 7735208322 · mburke@corvitahealth.org
- Edward M Burke · 7737297956 · eddie@corvitahealth.org
Similar studies in Illinois
All heart & blood pressure studies in Illinois →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Chicago, IL + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Chicago, IL + 27 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Chicago, IL + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Champaign, IL + 151 other US sites
- Eligibility basics
- Ages 40+